The ROE (Return on Equity) of Supernus Pharmaceuticals Inc (SUPN) is 7.13%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 7.13% |
| 2023-12-31 | 0.14% |
| 2022-12-31 | 6.85% |
| 2021-12-31 | 6.54% |
| 2020-12-31 | 17.05% |
| 2019-12-31 | 19.00% |
| 2018-12-31 | 24.50% |
| 2017-12-31 | 21.42% |
| 2016-12-31 | 47.55% |
| 2015-12-31 | 15.80% |